Skip to the page

Data / Form D filings / UPTAKE MEDICAL CORP

UPTAKE MEDICAL CORP: Form D filings

UPTAKE MEDICAL CORP, a biotechnology company in Tustin, CA, filed 10 Form D notices with the SEC between 2009 and 2016. The latest, on January 5, 2016, reports $2.4 million sold of a $3.5 million offering to 25 investors.

Find out what UPTAKE MEDICAL CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1173 Warner Avenue, Tustin, CA, 92780
Phone
(949) 440-1800
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1316760

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 5, 2016Amendment$3,500,000$2,396,389$1,103,61125Nov 24, 2015sec.gov
Dec 2, 2015New notice$3,500,000$1,928,783$1,571,2179Nov 24, 2015sec.gov
Mar 13, 2012Amendment$41,665,443$40,259,226$1,406,21738Dec 15, 2011sec.gov
Dec 27, 2011New notice$41,665,443$35,101,217$6,564,22637Dec 15, 2011sec.gov
Jul 13, 2011New notice$4,920,616$4,920,616$035Jun 30, 2011sec.gov
Aug 25, 2010Amendment$16,892,420$16,892,420$038Aug 31, 2009sec.gov
Jun 2, 2010New notice$600,600$600,600$06May 28, 2010sec.gov
Oct 8, 2009Amendment$13,363,514$4,582,208$8,781,30633Aug 31, 2009sec.gov
Sep 11, 2009New notice$13,363,515$3,359,505$10,004,0106Aug 31, 2009sec.gov
May 20, 2009Amendment$3,136,333$3,136,333$031Dec 22, 2008sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Carl King SimpsonDirector
David King SingerDirector
Krista King MannExecutive Officer
Geoff King BrookeDirector
Robert King KuhlingDirector
R. King NelsonExecutive Officer, Director
Sami King SindiDirector

Other biotechnology companies in California that filed recently

Every Form D from the week of Jan 4, 2016 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what UPTAKE MEDICAL CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.